ascendis pharma glp-1 receptor agonist weight management diabetes treatments Pharmacology Consult: agonists for loss Indications for GLP-1/GIP RA Summary
Description
doi: 10.2174/1381612826666201203145654
Author: Allison Nathan, Jenny Grimberg and Ashley Rhodes
Overall, the selected trials had a low to moderate risk of bias
The GHR-R antagonist JMV 2959 neither induces malaise nor alters the malaise property of LiCl in the adult male rat
* Liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound) are also FDA-approved for weight loss and weight management in patients with obesity without diabetes
